Regulations.gov document
Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID–19…
Notice · FDA-2020-D-1136 · posted Feb 10, 2023
Key facts
| Document ID | FDA-2020-D-1136-0081 |
|---|---|
| Title | Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID–19 Public Health Emergency; Withdrawal of Guidance |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2020-D-1136 |
| Posted | Feb 10, 2023 |
| Federal Register citation | 88 FR 8872 |
| FR document number | 2023-02809 |
| Comment period opens | Feb 10, 2023 |
| Effective date | Feb 10, 2023 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: